Norris Medicines14.07
-0.01 (+0.00%)

Norris Medicines Share Price

14.07-0.01 (+0.00%)
-14.47% past 1 Year

Corporate filings & documents

Announcements

Un-audited financial results for the quarter and half year ended 30th September 2026
1 week ago
Outcome Of Board Meeting Held Today I.E. Saturday November 14 2026
1 week ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Un-Audited Financial Results For the Quarter and half year ended September 30th 2026 And Other Matters.
2 weeks ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 inter alia to consider and approve Un-Audited Financial Results For the Quarter and half year ended September 30th 2026 And Other Matters.
2 weeks ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th September 2026
1 month ago
Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th September 2026
1 month ago
Scrutinizers Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Scrutinizers Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Scrutinizers Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Scrutinizers Report and Voting Results of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome and proceeding of the 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome of 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Outcome of 35th Annual General Meeting of the Company held on Tuesday 29th September 2026
1 month ago
Intimation of Closure of Trading Window
1 month ago
Intimation of Closure of Trading Window
1 month ago
Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
2 months ago
Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
2 months ago
Annual Report of the Company for the Financial year 2025-26.
2 months ago
Annual Report of the Company for the Financial year 2025-26.
2 months ago
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
2 months ago
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
2 months ago
Intimation of Book Closure for 35th AGM of the Company
2 months ago
Intimation of Book Closure for 35th AGM of the Company
2 months ago
Outcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
2 months ago
Outcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
2 months ago
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
3 months ago
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
3 months ago
Financial Results for the Quarter ended June 30 2026
3 months ago
Financial Results for the Quarter ended June 30 2026
3 months ago
Board Meeting held on August 14 2026 for the quarter ended June 30 2026.
3 months ago
Board Meeting held on August 14 2026 for the quarter ended June 30 2026.
3 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
3 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
3 months ago
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
3 months ago
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
3 months ago
Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
4 months ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
4 months ago
Intimation for Closure of Trading Window
5 months ago
Intimation for Closure of Trading Window
5 months ago
Appointment of Internal Auditor w.e.f 30.05.2026
5 months ago
Appointment of Internal Auditor w.e.f 30.05.2026
5 months ago
As per attachment.
5 months ago
As per attachment.
5 months ago
As per attachment.
5 months ago
As per attachment.
5 months ago

Concalls & investor presentations

Empty box

No presentations found

Norris Medicines Ltd Share Price Today

The Norris Medicines Ltd share price today is ₹16.3. During the trading session, the Norris Medicines Ltd share price opened at ₹16.9 and recorded an intraday high of ₹16.9 and a low of ₹16.3. Last closing price was ₹17.15. Over the past 52 weeks, the Norris Medicines Ltd share price has ranged between ₹12 and ₹20.06. The current Norris Medicines Ltd stock price reflects real-time market activity based on executed trades on the exchange.